Open AccessUTEROTONIC DRUGS IN THE PREVENTION OF POSTPARTUM HEMORRHAGES
Author(s) -
Zaituna Khamidullina,
A.Zh. Myrzabekova,
A.Zh. Syzdykova
Publication year - 2020
Publication title -
reproduktivnaâ medicina
Language(s) - English
Resource type - Journals
eISSN - 2960-1665
pISSN - 2303-9949
DOI - 10.37800/rm2020-1-37
Subject(s) - uterotonic , medicine , childbirth , caesarean section , obstetrics , postpartum period , pregnancy , maternal morbidity , postpartum bleeding , uterine inertia , oxytocin , biology , genetics
In the world practice, hemorrhages in obstetrics take leading positions within the causes of maternal morbidity and mortal ity. 800 women die every day due to childbirth complications under the data of the World Health Organization. The majority of maternal deaths occur during the perinatal period, usually within 24 hours postpartum. It is possible to prevent most of them. Lack of adequate pre-conceptional training, uncompensated extragenital diseases increase the percentage of pathological births. Consequently, practicing obstetricians-gynecologists have to face such childbirth complications as postpartum hemorrhage with increasing frequency. Uterine atonia is the main cause of postpartum hemorrhages. Uterotonic drugs administration enables to re- duce the risk of postpartum atonic hemorrhages. Particular attention should be paid to postpartum hemorrhage prevention, i.e. the use of uterotonic drugs as an integral part of the active management during the third period in natural labor and caesarean section.